Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension: the initial German experience
…, M Haas, C Hamm, T Kramm, S Guth… - European …, 2017 - Eur Respiratory Soc
Balloon pulmonary angioplasty (BPA) is an emerging treatment for patients with inoperable
chronic thromboembolic pulmonary hypertension (CTEPH). We report on a prospective …
chronic thromboembolic pulmonary hypertension (CTEPH). We report on a prospective …
Chronic thromboembolic pulmonary hypertension (CTEPH): updated recommendations from the Cologne Consensus Conference 2018
…, M Gerges, F Gerhardt, A Grgic, C Grohé, S Guth… - International journal of …, 2018 - Elsevier
Chronic thromboembolic pulmonary hypertension (CTEPH) is a subgroup of pulmonary
hypertension that differs from all other forms of PH in terms of its pathophysiology, patient …
hypertension that differs from all other forms of PH in terms of its pathophysiology, patient …
[HTML][HTML] Exercise training improves exercise capacity and quality of life in patients with inoperable or residual chronic thromboembolic pulmonary hypertension
C Nagel, F Prange, S Guth, J Herb, N Ehlken, C Fischer… - 2012 - journals.plos.org
Background Aim of this prospective study was to evaluate the effects of exercise training in
patients with inoperable or residual chronic thromboembolic pulmonary hypertension (CTEPH…
patients with inoperable or residual chronic thromboembolic pulmonary hypertension (CTEPH…
Sequential treatment with riociguat and balloon pulmonary angioplasty for patients with inoperable chronic thromboembolic pulmonary hypertension
…, A Rieth, CW Hamm, E Mayer, S Guth… - Pulmonary …, 2018 - journals.sagepub.com
Riociguat is the treatment of choice for inoperable patients with chronic thromboembolic
pulmonary hypertension (CTEPH). We addressed here whether additional balloon pulmonary …
pulmonary hypertension (CTEPH). We addressed here whether additional balloon pulmonary …
[HTML][HTML] Current strategies for managing chronic thromboembolic pulmonary hypertension: results of the worldwide prospective CTEPH Registry
S Guth, AM D'Armini, M Delcroix… - ERJ open …, 2021 - Eur Respiratory Soc
Background Pulmonary endarterectomy (PEA), pulmonary arterial hypertension (PAH)
therapy and balloon pulmonary angioplasty (BPA) are currently accepted therapies for chronic …
therapy and balloon pulmonary angioplasty (BPA) are currently accepted therapies for chronic …
Chronic thromboembolic pulmonary hypertension (CTEPH): updated recommendations of the Cologne Consensus Conference 2011
…, I Lang, J Behr, T Berghaus, C Grohe, S Guth… - International journal of …, 2011 - Elsevier
In the 2009 European Guidelines on the diagnosis and treatment of pulmonary hypertension
(PH), one section covers aspects of pathophysiology, diagnosis and treatment of chronic …
(PH), one section covers aspects of pathophysiology, diagnosis and treatment of chronic …
Inhaled iloprost to control residual pulmonary hypertension following pulmonary endarterectomy
T Kramm, B Eberle, S Guth… - European journal of cardio …, 2005 - academic.oup.com
Objective: Pulmonary endarterectomy (PEA) is the standard therapy for patients with chronic
thromboembolic pulmonary hypertension (CTEPH). In the immediate postoperative period, …
thromboembolic pulmonary hypertension (CTEPH). In the immediate postoperative period, …
[HTML][HTML] Anxiety and depression disorders in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
…, HJ Seyfarth, M Halank, E Mayer, E Grünig, S Guth - Respiratory …, 2013 - Springer
Background The objective of this prospective study was to assess the prevalence of anxiety
and depression disorders and their association with quality of life (QoL), clinical parameters …
and depression disorders and their association with quality of life (QoL), clinical parameters …
Combined pulmonary endarterectomy and balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension
…, C Liebetrau, A Breithecker, S Guth… - The Journal of Heart and …, 2016 - Elsevier
Background Pulmonary endarterectomy (PEA) is a curative treatment option for more than
60% of patients with chronic thromboembolic pulmonary hypertension (CTEPH). For selected …
60% of patients with chronic thromboembolic pulmonary hypertension (CTEPH). For selected …
[HTML][HTML] Incidence and characteristics of chronic thromboembolic pulmonary hypertension in Germany
…, H Wilkens, J Fuge, HJ Schäfers, S Guth… - Clinical Research in …, 2018 - Springer
Background The incidence of chronic thromboembolic pulmonary hypertension (CTEPH) is
unknown. Previous studies from the United Kingdom and Spain have reported incidence …
unknown. Previous studies from the United Kingdom and Spain have reported incidence …